A comprehensive multiomics approach toward understanding the relationship between aging and dementia

Aging

Volumn 7, Issue 11, 2015, Pages 937-955

  Currais, Antonio ^a   Goldberg, Joshua ^a   Farrokhi, Catherine ^a   Chang, Max ^a   Prior, Marguerite ^a   Dargusch, Richard ^a   Daugherty, Daniel ^a   Armando, Aaron ^b   Quehenberger, Oswald ^b   Maher, Pamela ^a   Schubert, David ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Aging; Alzheimer's disease; Inflammation; J147; Multiomics; SAMP8 mice

Indexed keywords

AMYLOID BETA PROTEIN; GLUTATHIONE; ICOSANOID; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTOME;

AGING; ALZHEIMER DISEASE; ANIMAL; ANIMAL BEHAVIOR; BLOOD BRAIN BARRIER; DRUG EFFECTS; HIPPOCAMPUS; HUMAN; MAZE TEST; METABOLISM; METABOLOMICS; MOUSE; PHYSIOLOGY;

AGING; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BEHAVIOR, ANIMAL; BLOOD-BRAIN BARRIER; EICOSANOIDS; GLUTATHIONE; HIPPOCAMPUS; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAZE LEARNING; METABOLOMICS; MICE; TRANSCRIPTOME;

EID: 84949935464     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/aging.100838     Document Type: Article

References (49)

1. Prior M, Chiruta C, Currais A, Goldberg J, Ramsey J, Dargusch R, Maher PA and Schubert D. Back to the future with phenotypic screening. ACS Chem Neurosci. 2014; 5:503-513.
2. Chen Q, Prior M, Dargusch R, Roberts A, Riek R, Eichmann C, Chiruta C, Akaishi T, Abe K, Maher P and Schubert D. A novel neurotrophic drug for cognitive enhancement and Alzheimer's disease. PLoS One. 2011; 6:e27865.
3. Prior M, Dargusch R, Ehren JL, Chiruta C and Schubert D. The neurotrophic compound J147 reverses cognitive impairment in aged Alzheimer's disease mice. Alzheimers Res Ther. 2013; 5:25.
4. Swerdlow RH. Is aging part of Alzheimer's disease, or is Alzheimer's disease part of aging? Neurobiol Aging. 2007; 28:1465-1480.
5. Cheng XR, Zhou WX and Zhang YX. The behavioral, pathological and therapeutic features of the senescenceaccelerated mouse prone 8 strain as an Alzheimer's disease animal model. Ageing Res Rev. 2014; 13:13-37.
6. Morley JE, Armbrecht HJ, Farr SA and Kumar VB. The senescence accelerated mouse (SAMP8) as a model for oxidative stress and Alzheimer's disease. Biochim Biophys Acta. 2012; 1822:650-656.
7. Currais A, Prior M, Lo D, Jolivalt C, Schubert D and Maher P. Diabetes exacerbates amyloid and neurovascular pathology in aging-accelerated mice. Aging Cell. 2012; 11:1017-1026.
8. Morley JE, Farr SA, Kumar VB and Armbrecht HJ. The SAMP8 mouse: a model to develop therapeutic interventions for Alzheimer's disease. Curr Pharm Des. 2012; 18:1123-1130.
9. Chang RC, Wong AK, Ng HK and Hugon J. Phosphorylation of eukaryotic initiation factor-2alpha (eIF2alpha) is associated with neuronal degeneration in Alzheimer's disease. Neuroreport. 2002; 13:2429-2432.
10. Thinakaran G and Koo EH. Amyloid precursor protein trafficking, processing, and function. J Biol Chem. 2008; 283:29615-29619.
11. Ikura Y, Kudo T, Tanaka T, Tanii H, Grundke-Iqbal I, Iqbal K and Takeda M. Levels of tau phosphorylation at different sites in Alzheimer disease brain. Neuroreport. 1998; 9:2375-2379.
12. Wyss-Coray T and Rogers J. Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature. Cold Spring Harb Perspect Med. 2012; 2:a006346.
13. Grammas P. Neurovascular dysfunction, inflammation and endothelial activation: implications for the pathogenesis of Alzheimer's disease. J Neuroinflammation. 2011; 8:26.
14. Pelegri C, Canudas AM, del Valle J, Casadesus G, Smith MA, Camins A, Pallas M and Vilaplana J. Increased permeability of blood-brain barrier on the hippocampus of a murine model of senescence. Mech Ageing Dev. 2007; 128:522-528.
15. Rodriguez JJ, Olabarria M, Chvatal A and Verkhratsky A. Astroglia in dementia and Alzheimer's disease. Cell Death Differ. 2009; 16:378-385.
16. Ploia C, Antoniou X, Sclip A, Grande V, Cardinetti D, Colombo A, Canu N, Benussi L, Ghidoni R, Forloni G and Borsello T. JNK plays a key role in tau hyperphosphorylation in Alzheimer's disease models. J Alzheimers Dis. 2011; 26:315-329.
17. Buczynski MW, Dumlao DS and Dennis EA. Thematic Review Series: Proteomics. An integrated omics analysis of eicosanoid biology. J Lipid Res. 2009; 50:1015-1038.
18. Morin C, Fortin S and Rousseau E. 19,20-EpDPE, a bioactive CYP450 metabolite of DHA monoacyglyceride, decreases Ca(2)(+) sensitivity in human pulmonary arteries. Am J Physiol Heart Circ Physiol. 2011; 301:H1311-1318.
19. Viswanathan S, Hammock BD, Newman JW, Meerarani P, Toborek M and Hennig B. Involvement of CYP 2C9 in mediating the proinflammatory effects of linoleic acid in vascular endothelial cells. J Am Coll Nutr. 2003; 22:502-510.
20. Hardwick JP, Eckman K, Lee YK, Abdelmegeed MA, Esterle A, Chilian WM, Chiang JY and Song BJ. Eicosanoids in metabolic syndrome. Adv Pharmacol. 2013; 66:157-266.
21. Lin MT and Beal MF. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature. 2006; 443:787-795.
22. Carlyle BC, Nairn AC, Wang M, Yang Y, Jin LE, Simen AA, Ramos BP, Bordner KA, Craft GE, Davies P, Pletikos M, Sestan N, Arnsten AF, et al. cAMP-PKA phosphorylation of tau confers risk for degeneration in aging association cortex. Proc Natl Acad Sci U S A. 2014; 111:5036-5041.
23. Leak RK. Heat shock proteins in neurodegenerative disorders and aging. J Cell Commun Signal. 2014.
24. Li C, Zhao R, Gao K, Wei Z, Yin MY, Lau LT, Chui D and Hoi Yu AC. Astrocytes: implications for neuroinflammatory pathogenesis of Alzheimer's disease. Curr Alzheimer Res. 2011; 8:67-80.
25. Mosher KI and Wyss-Coray T. Microglial dysfunction in brain aging and Alzheimer's disease. Biochem Pharmacol. 2014; 88:594-604.
26. Waetzig V, Czeloth K, Hidding U, Mielke K, Kanzow M, Brecht S, Goetz M, Lucius R, Herdegen T and Hanisch UK. c-Jun Nterminal kinases (JNKs) mediate pro-inflammatory actions of microglia. Glia. 2005; 50:235-246.
27. Rubio-Perez JM and Morillas-Ruiz JM. A review: inflammatory process in Alzheimer's disease, role of cytokines. ScientificWorldJournal. 2012; 2012:756357.
28. Yurko-Mauro K. Cognitive and cardiovascular benefits of docosahexaenoic acid in aging and cognitive decline. Curr Alzheimer Res. 2010; 7:190-196.
29. Green KN, Martinez-Coria H, Khashwji H, Hall EB, Yurko-Mauro KA, Ellis L and LaFerla FM. Dietary docosahexaenoic acid and docosapentaenoic acid ameliorate amyloid-beta and tau pathology via a mechanism involving presenilin 1 levels. J Neurosci. 2007; 27:4385-4395.
30. Lim GP, Calon F, Morihara T, Yang F, Teter B, Ubeda O, Salem N, Jr., Frautschy SA and Cole GM. A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model. J Neurosci. 2005; 25:3032-3040.
31. Navarro A and Boveris A. Brain mitochondrial dysfunction in aging, neurodegeneration, and Parkinson's disease. Front Aging Neurosci. 2010; 2:1-11.
32. Zhang H, Forman HJ and Choi J. Gamma-glutamyl transpeptidase in glutathione biosynthesis. Methods Enzymol. 2005; 401:468-483.
33. Valerio A, D'Antona G and Nisoli E. Branched-chain amino acids, mitochondrial biogenesis, and healthspan: an evolutionary perspective. Aging (Albany NY). 2011; 3:464-478.
34. Houtkooper RH, Argmann C, Houten SM, Canto C, Jeninga EH, Andreux PA, Thomas C, Doenlen R, Schoonjans K and Auwerx J. The metabolic footprint of aging in mice. Sci Rep. 2011; 1:134.
35. Rutkowsky JM, Knotts TA, Ono-Moore KD, McCoin CS, Huang S, Schneider D, Singh S, Adams SH and Hwang DH. Acylcarnitines activate proinflammatory signaling pathways. Am J Physiol Endocrinol Metab. 2014; 306:E1378-1387.
36. Trushina E, Dutta T, Persson XM, Mielke MM and Petersen RC. Identification of altered metabolic pathways in plasma and CSF in mild cognitive impairment and Alzheimer's disease using metabolomics. PLoS One. 2013; 8:e63644.
37. Zahr NM, Mayer D, Pfefferbaum A and Sullivan EV. Low striatal glutamate levels underlie cognitive decline in the elderly: evidence from in vivo molecular spectroscopy. Cereb Cortex. 2008; 18:2241-2250.
38. Fayed N, Modrego PJ, Rojas-Salinas G and Aguilar K. Brain glutamate levels are decreased in Alzheimer's disease: a magnetic resonance spectroscopy study. Am J Alzheimers Dis Other Demen. 2011; 26(6):450-456.
39. Rupsingh R, Borrie M, Smith M, Wells JL and Bartha R. Reduced hippocampal glutamate in Alzheimer disease. Neurobiol Aging. 2011; 32:802-810.
40. Liu F, Liang Z, Shi J, Yin D, El-Akkad E, Grundke-Iqbal I, Iqbal K and Gong CX. PKA modulates GSK-3beta-and cdk5-catalyzed phosphorylation of tau in site-and kinase-specific manners. FEBS Lett. 2006; 580:6269-6274.
41. de Magalhaes JP. How ageing processes influence cancer. Nat Rev Cancer. 2013; 13:357-365.
42. Stefanova NA, Muraleva NA, Korbolina EE, Kiseleva E, Maksimova KY and Kolosova NG. Amyloid accumulation is a late event in sporadic Alzheimer's disease-like pathology in nontransgenic rats. Oncotarget. 2015; 6:1396-1413.
43. Currais A, Prior M, Dargusch R, Armando A, Ehren J, Schubert D, Quehenberger O and Maher P. Modulation of p25 and inflammatory pathways by fisetin maintains cognitive function in Alzheimer's disease transgenic mice. Aging Cell. 2014; 13:379-390.
44. Shin SY, Fauman EB, Petersen AK, Krumsiek J, Santos R, Huang J, Arnold M, Erte I, Forgetta V, Yang TP, Walter K, Menni C, Chen L, et al. An atlas of genetic influences on human blood metabolites. Nat Genet. 2014; 46:543-550.
45. Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M and Gingeras TR. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013; 29:15-21.
46. Liao Y, Smyth GK and Shi W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014; 30:923-930.
47. Love MI, Huber W and Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014; 15:550.
48. Edgar R, Domrachev M and Lash AE. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2002; 30(:207-210.
49. Xia J, Mandal R, Sinelnikov IV, Broadhurst D and Wishart DS. MetaboAnalyst 2.0-a comprehensive server for metabolomic data analysis. Nucleic Acids Res. 2012; 40:W127-133.